Trade Summary
5 days ago, Broadwood Partners, L.P., serving as 10% owner at Insight Molecular Diagnostics Inc. (IMDX), purchased 182,861 shares at $3.57 per share, for a total transaction value of $652,876.00. Following this transaction, Broadwood Partners, L.P. now holds 24,229,557 shares of IMDX.
This purchase represents a 1.00% increase in Broadwood Partners, L.P.'s stake in the company. This is considered a medium-conviction trade.
The trade was executed on Thursday, April 16, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 20, 2026, 4 days after the trade was made.
Insight Molecular Diagnostics Inc. operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.
